OverviewSuggest Edit

Merck Group is a pharmaceutical, chemical, and life sciences company. It operates in three business sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector develops and manufactures prescription pharmaceuticals, biopharmaceuticals, allergy products, and medical devices. The Life Science sector provides products for scientific institutions and research and analytical laboratories in the pharmaceutical and biotechnology industry and applications for customers manufacturing chemical and biological pharmaceuticals. The Performance Materials sector delivers specialty chemicals primarily to industrial companies.

TypePublic
Founded1668
HQDarmstadt, DE
Websitemerckgroup.com
Employee Ratings4
Overall CultureC+

Latest Updates

Employees (est.) (Dec 2020)58,127(+2%)
Job Openings1,662
Revenue (FY, 2020)€17.5 B(+9%)
Share Price (Sept 2021)€199.7(-1%)
Cybersecurity ratingBMore

Key People/Management at Merck Group

Belén Garijo

Belén Garijo

Chair of the Executive Board and CEO of Merck
Kai Beckmann

Kai Beckmann

Member of the Executive Board, CEO Electronics
Marcus Kuhnert

Marcus Kuhnert

Member of the Executive Board, Chief Financial Officer
Peter Guenter

Peter Guenter

Member of the Executive Board, CEO Healthcare
Matthias Heinzel

Matthias Heinzel

Member of the Executive Board, CEO Life Science
Show more

Merck Group Office Locations

Merck Group has offices in Darmstadt, Gernsheim, Hohenbrunn, Menlo Park and in 106 other locations
Darmstadt, DE (HQ)
Frankfurter Str. 250
Darmstadt, DE
Alsfelder Str. 17
Darmstadt, DE
Feldbergstraße 80
Darmstadt, DE
Goebelstraße 1-3
Gernsheim, DE
Mainzer Str. 41
Hohenbrunn, DE
Eduard-Buchner-Straße 14-20
Show all (121)

Merck Group Financials and Metrics

Merck Group Revenue

Embed Graph
View revenue for all periods
Merck Group's revenue was reported to be €17.53 b in FY, 2020 which is a 8.6% increase from the previous period.
EUR

Revenue (Q2, 2021)

4.9b

Gross profit (Q2, 2021)

3.1b

Gross profit margin (Q2, 2021), %

62.8%

Net income (Q2, 2021)

746.8m

EBITDA (Q2, 2021)

1.5b

EBIT (Q2, 2021)

1.0b

Market capitalization (14-Sept-2021)

86.9b

Closing stock price (14-Sept-2021)

199.7

Cash (30-Jun-2021)

1.8b

EV

97.1b
Merck Group's current market capitalization is €86.9 b.
Annual
EURFY, 2018FY, 2019FY, 2020

Revenue

14.8b16.2b17.5b

Revenue growth, %

(3%)9%9%

Cost of goods sold

5.4b6.0b6.8b

Gross profit

9.5b10.1b10.7b
Quarterly
EURQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Revenue

3.7b4.0b4.1b4.4b4.1b4.4b4.6b4.9b

Cost of goods sold

1.4b1.5b1.5b1.7b1.6b1.8b1.7b1.8b

Gross profit

2.4b2.5b2.6b2.7b2.5b2.7b2.9b3.1b

Gross profit Margin, %

63%63%64%62%61%60%63%63%
Annual
EURFY, 2018FY, 2019FY, 2020

Cash

2.2b781.0m1.4b

Accounts Receivable

2.9b3.5b3.2b

Inventories

2.8b3.3b3.3b

Current Assets

9.2b9.0b9.3b
Quarterly
EURQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Cash

2.3b3.5b5.1b1.5b1.5b1.5b2.2b1.8b

Accounts Receivable

3.6b3.5b3.4b3.7b3.5b3.5b3.7b3.7b

Inventories

2.9b3.0b3.1b3.4b3.5b3.4b3.5b3.6b

Current Assets

10.5b11.7b13.5b10.0b9.7b10.3b10.6b10.2b
Annual
EURFY, 2018FY, 2019FY, 2020

Depreciation and Amortization

1.8b1.9b1.9b

Inventories

(172.0m)(324.0m)(85.0m)

Accounts Payable

104.0m201.0m7.0m

Cash From Operating Activities

2.2b2.9b3.5b
Quarterly
EURQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Depreciation and Amortization

474.0m927.0m1.4b431.0m991.0m1.4b424.0m843.1m

Inventories

(145.7m)(258.9m)(316.4m)(129.0m)(247.0m)(195.2m)(108.0m)(224.7m)

Accounts Payable

(17.5m)141.3m128.0m27.0m(42.0m)12.1m333.8m347.7m

Cash From Operating Activities

492.5m1.2b2.2b516.0m1.0b2.2b1.2b2.1b
EURFY, 2018

Revenue/Employee

286.9k

Debt/Equity

0.5 x

Debt/Assets

0.2 x

Financial Leverage

2.1 x
Show all financial metrics

Merck Group Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020

Countries

66666666

Legal Entities

217207222221

Products

300 k300 k300 k300 k

Scientists and Researchers

6 k7 k7.8 k7.9 k
Show all operating metrics

Merck Group Acquisitions / Subsidiaries

Company NameDateDeal Size
AmpTecJanuary 07, 2021
RESOLUTION Spectra SystemsJuly 01, 2020
Flodesign SonicsOctober 10, 2019
FloDesign SonicsOctober 10, 2019
Intermolecular IncMay 06, 2019
Versum Materials, IncApril 12, 2019
Grzybowski Scientific InventionsMay 10, 2017
BioControlJanuary 04, 2017
Ormet Circuits IncDecember 16, 2015
Sigma-AldrichNovember 18, 2015
Show more

Merck Group Revenue Breakdown

Embed Graph

Merck Group revenue breakdown by business segment: 19.3% from Performance Materials, 42.9% from Life Science and 37.9% from Healthcare

Merck Group revenue breakdown by geographic segment: 5.2% from Latin America, 36.0% from Asia-Pacific, 27.0% from North America, 28.5% from Europe and 3.3% from Other

Show all human capital metrics

Merck Group Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

Merck Group Online and Social Media Presence

Embed Graph

Merck Group Company Culture

  • Overall Culture

    C+

    67/100

  • CEO Rating

    D

    58/100

  • Compensation

    D

    49/100

Learn more on Comparably

Merck Group News and Updates

Merck KGaA says lab supplies business can grow by up to ...

Merck KGaA says lab supplies business can grow by up to ...

Merck KGaA lifts growth forecast for life science tools business By Reuters

Merck KGaA lifts growth forecast for life science tools business By Reuters

Diaccurate Acquires Clinical Stage Sole - in - Class Targeted Cancer Therapy from Merck KGaA , Darmstadt , Germany

Diaccurate Acquires Clinical Stage Sole - in - Class Targeted Cancer Therapy from Merck KGaA , Darmstadt , Germany

Merck : Morgan Stanley dégrade sa recommandation

Merck: Morgan Stanley downgrades its recommendation

GSK/Merck KGgA cancer drug fails in third trial

Merck has announced that its phase 2 INTR@PID BTC 055 study evaluating bintrafusp alfa with gemcitabine plus cisplatin in the first-line treatment of patients with locally advanced or metastatic biliary tract cancer (BTC) is to be discontinued, after an independent data monitoring committee judged t…
Show more

Merck Group Frequently Asked Questions

  • When was Merck Group founded?

    Merck Group was founded in 1668.

  • Who are Merck Group key executives?

    Merck Group's key executives are Belén Garijo, Kai Beckmann and Marcus Kuhnert.

  • How many employees does Merck Group have?

    Merck Group has 58,127 employees.

  • What is Merck Group revenue?

    Latest Merck Group annual revenue is €17.5 b.

  • What is Merck Group revenue per employee?

    Latest Merck Group revenue per employee is €301.7 k.

  • Who are Merck Group competitors?

    Competitors of Merck Group include Merck, Johnson & Johnson and Pfizer.

  • Where is Merck Group headquarters?

    Merck Group headquarters is located at Frankfurter Str. 250, Darmstadt.

  • Where are Merck Group offices?

    Merck Group has offices in Darmstadt, Gernsheim, Hohenbrunn, Menlo Park and in 106 other locations.

  • How many offices does Merck Group have?

    Merck Group has 121 offices.